Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters








Language
Year range
1.
Article in English | IMSEAR | ID: sea-166818

ABSTRACT

Germander (Teucrium polium) is commonly used as medicinal plant in Algeria against a variety of human diseases. This study aims to evaluate toxic effects of T. polium methanol extract (TPME) in Swiss albino mice. Biochemical parameters, organs morophology and histopathology were investigated. TPME gave a LD50 of 442.81 and 686.77 mg/kg of body weight (b.w.) in male and female mice, respectively. The acute treatment for seven days at a dose of 100 mg/kg of b.w. didn’t show any difference in body weight, relative mass and blood biochemical parameters. Histopathological examination revealed a moderate congestion in kidneys and an inflammatory infiltrate in liver. The chronic effect for 30 days at doses of 50 and 75 mg of TPME/kg of b.w. resulted in a significant increase of renal (urea), hepatic (aspartate aminotransferase and alanine aminotransferase) parameters, accompanied by a significant decrease of cholesterol level. Histopathological examination confirmed the biochemical tests by the observation of necrosis areas, ballooning degeneration and peliosis in liver sections and the presence of marked vascular congestion in kidneys in both sexes. In conclusion, the use of Teucrium polium L. may cause hepatotoxicity and nephrotoxicity after prolonged herb administration.

2.
Rev. bras. farmacogn ; 22(1): 102-108, Jan.-Feb. 2012. graf, tab
Article in English | LILACS | ID: lil-607587

ABSTRACT

This study aimed to evaluate the safety of the hydroalcoholic extract (HE) of Syzygium cumini (L.) Skeels, Myrtaceae, leaves in rodents. Acute toxicity was evaluated through the determination of a LD50 in mice and rats (up to 14 days). In mice, the oral administration (p.o.) of the HE (0.1 at 6 g/kg) did not cause any death. When administered by intraperitoneal route (i.p.) the HE (0.1 at 1 g/kg) caused death of the animals (LD50 of 0.489 g/kg). In rats, the HE (0.5, 1 and 2 g/kg, p.o.) did not cause any death, while by i.p., only the 2 g/kg dose was lethal to 67 percent of the animals. To evaluate chronic toxicity, groups of rats daily received the HE (0.05, 0.1 and 0.25 g/kg) through p.o., during 30, 90 or 180 days and the effects on behavior, body weight, feed consumed were measured. Histology, hematology and biochemical parameters were measured at the end of the treatment. After a 30-day treatment, the HE caused changes in some biochemical parameters. Histological examination of the liver, kidneys, lungs, heart, stomach, intestine and pancreas showed normal architecture suggesting no morphological disturbances. These data may mean that the HE of S. cumini does not exert acute or chronic toxic effects by oral administration.

3.
J Environ Biol ; 2012 Jan; 33(1): 139-142
Article in English | IMSEAR | ID: sea-146678

ABSTRACT

Acute toxicity of copper (Cu) on Chironomus ramosus was determined by exposing third-instar larvae to graded concentrations of copper sulphate (CuSO4. 5H2O). Median lethal concentrations (LC50) of Cu as CuSO4 at 24, 48, 72 and 96 hr were determined as 3280, 1073.33, 780, and 183 μg l-1, respectively. For determining the effects of chronic toxicity, small first-instar larvae were individually exposed to sublethal concentrations of copper sulphate (1.0-18.0 μg l-1) for a period of 21 days. Discoloration and thinning of body were detected at 1 μg l-1 and ventilation movements, pupation and adult emergence were significantly affected at 1.8 μg l-1. At 10 μg l-1 CuSO 4 concentration, growth and tube-building activities of the larva were significantly different from the control.

4.
Rev. bras. farmacogn ; 18(supl): 676-682, Dec. 2008. tab
Article in English | LILACS | ID: lil-509463

ABSTRACT

Ierobina® is a Brazilian phytopharmaceutical product employed for the treatment of dyspepsia (280 mg/kg/day). Despite its widespread use in the country for over 75 years, only recently its therapeutic efficacy has been attested in animals; however, no toxicological investigations have been carried out for the product to date. In this paper we evaluated the acute toxicity of Ierobina® administrated by gavage in mice (single doses of 2100 mg/kg, 6300 mg/kg and 12600 mg/kg), along with its chronic effects in rats, after product administration per os daily, at the doses of 2800 mg/kg and 5600 mg/kg, for 180 days. The product had low acute toxicity; all observed alterations were reversible and no animal died during the experiments. In chronic toxicological studies, Ierobina® administration for 180 days did not cause any changes in hematological and biochemical parameters, with the exception of decreasing the levels of alanine transaminase, aspartate transaminase and creatinine. However, histological evaluation of kidney, liver and other selected organs showed normal architecture, suggesting no morphological disturbances. Hence, considering the obtained results and the fact that Ierobina® has been commercialized for decades in Brazil, without any notified case of toxicity, it seems that the product is safe for human use.


A Ierobina® é um produto utilizado popularmente, no Brasil, para tratamento de dispepsia, na dose de 280 mg/kg/dia. Apesar de seu largo uso nos últimos 75 anos, recentemente foi comprovada sua eficácia em animais; porém, nenhuma avaliação de seu perfil toxicológico foi realizada. O objetivo do presente estudo foi avaliar a toxicidade aguda (doses únicas de 2100 mg/kg, 6300 mg/kg ou 12600 mg/kg), em camundongos, e crônica (doses de 2800 mg/kg ou 5600 mg/kg, por 180 dias), em ratos, após administração per os de Ierobina®. No teste de toxicidade aguda, as doses administradas não produziram nenhuma mortalidade e os sinais observados foram todos reversíveis. No teste de toxicidade crônica, não foram verificadas diferenças significativas nas análises hematológicas, macroscópicas e microscópicas. Nos exames de bioquímica sérica, diferença significativa foi observada somente na avaliação da alanina transaminase, aspartato transaminase e creatinina, porém, sem importância clínica. Assim, considerando os resultados obtidos e o fato de ser a Ierobina® um produto comercializado há décadas, sem qualquer notificação de casos de toxicidade, podemos concluir que o produto parece ser de segurança adequada para uso humano.

SELECTION OF CITATIONS
SEARCH DETAIL